δ-Ava7-Atosiban is a modified atosiban analogue featuring δ-Ava substitution to adjust conformational and physicochemical properties. The change influences backbone flexibility, hydrophobic surface, and receptor-contact regions. Researchers compare its structural ensemble and binding behavior with the parent peptide. Applications include analog-optimization work, SAR exploration, and peptide-structure refinement.
CAT No: R2849
Synonyms/Alias:(4R,7S,10S,13S,16R)-N-(5-(((S)-5-amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)amino)-5-oxopentyl)-7-(2-amino-2-oxoethyl)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More